Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and Adults

被引：0
|
作者：
Axel De Greef
Pierre-Dominique Ghislain
Laurence de Montjoye
Marie Baeck
机构：
[1] Cliniques Universitaires Saint-Luc (UCLouvain),Department of Dermatology
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Atopic dermatitis; Real-life study; JAK inhibitor; Upadacitinib; Effectiveness; Tolerance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2509 / 2514
页数：5
相关论文
共 50 条
  • [31] Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience
    Napolitano, Maddalena
    Potestio, Luca
    Hansel, Katharina
    Marietti, Rossella
    Piscitelli, Ilaria
    Fabbrocini, Gabriella
    Stingeni, Luca
    Patruno, Cataldo
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (03) : 247 - 249
  • [32] Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study
    Vignoli, Carlo Alberto
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [33] Real-life experience with dupilumab in 56 children and adolescents aged 2 to 17 with uncontrolled moderate-to-severe atopic dermatitis
    Colonna, Cristiana
    Monzani, Nicola A.
    Quattri, Eleonora
    Montefusco, Francesca
    Cavalli, Riccardo
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2024, 159 (06) : 694 - 695
  • [34] Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life study
    Chiei-Gallo, Alessandra
    Barei, Francesca
    Calzari, Paolo
    Pisapia, Armando
    Marzano, Angelo V.
    Ferrucci, Silvia M.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
  • [35] Upadacitinib for moderate-to-severe atopic dermatitis, in adults and adolescents 12 years and older: review of international and Japanese populations
    Kishimoto, Mitsumasa
    Deshpande, Gautam A.
    Fukui, Sho
    Komagata, Yoshinori
    Ohyama, Manabu
    Kaname, Shinya
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) : 19 - 35
  • [36] Therapeutic Modulation of Dupilumab in Patients with Severe Atopic Dermatitis: Clinical Effectiveness in Real Life
    Mastorino, Luca
    Borrelli, Richard
    Macagno, Nicole
    Gelato, Federica
    Baima, Erica
    Richiardi, Irene
    Cavaliere, Giovanni
    Quaglino, Pietro
    Ortoncelli, Michela
    Ribero, Simone
    DERMATITIS, 2024, 35 (06) : 625 - 635
  • [37] Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
    Faiz, Sarah
    Giovannelli, Jonathan
    Podevin, Celine
    Jachiet, Marie
    Bouaziz, Jean-David
    Reguiai, Ziad
    Nosbaum, Audrey
    Lasek, Audrey
    le Bouedec, Marie-Christine Ferrier
    Aurelie Du Thah
    Raison-Peyron, Nadia
    Tetart, Florence
    Duval-Modeste, Anne-Benedicte
    Misery, Laurent
    Aubin, Francois
    Dompmartin, Anne
    Morice, Cecile
    Droitcourt, Catherine
    Soria, Angele
    Arnault, Jean-Philippe
    Delaunay, Juliette
    Mahe, Emmanuel
    Richard, Marie-Aleth
    Schoeffler, Amelie
    Lacour, Jean-Philippe
    Begon, Edouard
    Walter-Lepage, Amelie
    Dillies, Anne-Sophie
    Rappelle-Duruy, Sandrine
    Barete, Stephane
    Bellon, Nathalia
    Beneton, Nathalie
    Valois, Aude
    Barbarot, Sebastien
    Senechal, Julien
    Staumont-Salle, Delphine
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) : 143 - 151
  • [38] Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study
    Hagino, Teppei
    Hamada, Risa
    Yoshida, Mai
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    PHARMACEUTICALS, 2024, 17 (04)
  • [39] Real-world Experience With Upadacitinib in Adolescents and Adults With Refractory Atopic Dermatitis: A 24-week Retrospective Study
    Naharro-Rodriguez, J.
    Berna-Rico, E.
    Perez-Bootelloy, F. J.
    Perez-Garcia, B.
    ACTAS DERMO-SIFILIOGRAFICAS, 2024, 115 (06): : T615 - T617
  • [40] Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience
    Rogner, Danielle
    Biedermann, Tilo
    Lauffer, Felix
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
12345